Burke Matthew J, Fried Peter J, Pascual-Leone Alvaro
Berenson-Allen Center for Noninvasive Brain Stimulation and Division of Cognitive Neurology, Department of Neurology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, United States.
Berenson-Allen Center for Noninvasive Brain Stimulation and Division of Cognitive Neurology, Department of Neurology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, United States; Guttmann Brain Health Institute, Institut Guttmann de Neurorehabilitacio, Universitat Autonoma de Barcelona, Barcelona, Spain; Marcus Institute for Aging Research, Hebrew Senior Life, Harvard Medical School, Boston, MA, United States.
Handb Clin Neurol. 2019;163:73-92. doi: 10.1016/B978-0-12-804281-6.00005-7.
Transcranial magnetic stimulation (TMS) is a safe and noninvasive means of electrically stimulating the brain by electromagnetic induction. TMS is capable of probing intracortical circuits and modulating cortical activity in humans; as such it has been instrumental to studying the neurophysiology and functional neuroanatomy of the frontal lobes. For example, using TMS to induce "virtual lesions"-transient disruption of function in the targeted brain region-has yielded important insights into the functional organization of the prefrontal cortex (PFC) with respect to working memory, language, and other core cognitive functions. Whereas neuroimaging is typically limited to observing correlations between brain function and behavior, TMS, by interacting with neural circuits, can lead to causal inferences that bridge human, nonhuman primate, and other model system studies. Applied repetitively in trains of stimuli, TMS is also capable of normalizing aberrant patterns of cortical activity in the treatment of neurologic and psychiatric disorders. The earliest and most well-established clinical use of repetitive TMS is in the treatment of medication-resistant depression with high-frequency stimulation of the left dorsolateral PFC. Research efforts to identify other promising clinical applications-such as for stroke and Alzheimer's disease-are rapidly expanding; however, the majority of these indications have yet to have devices cleared by the FDA for on-label use.
经颅磁刺激(TMS)是一种通过电磁感应对大脑进行电刺激的安全且无创的方法。TMS能够探测人类大脑皮质内的神经回路并调节皮质活动;因此,它对研究额叶的神经生理学和功能性神经解剖学起到了重要作用。例如,利用TMS诱发“虚拟损伤”——即目标脑区功能的短暂中断——已使人们对前额叶皮质(PFC)在工作记忆、语言及其他核心认知功能方面的功能组织有了重要认识。神经成像通常仅限于观察脑功能与行为之间的相关性,而TMS通过与神经回路相互作用,能够得出因果推断,从而将人类、非人类灵长类动物及其他模型系统的研究联系起来。以一连串刺激重复应用时,TMS还能够在治疗神经和精神疾病时使异常的皮质活动模式正常化。重复TMS最早且最成熟的临床应用是通过高频刺激左侧背外侧PFC来治疗难治性抑郁症。确定其他有前景的临床应用(如用于中风和阿尔茨海默病)的研究工作正在迅速扩展;然而,这些适应症中的大多数尚未有经美国食品药品监督管理局(FDA)批准用于标签注明用途的设备。